Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

researchers recommended that people who received it get a second booster dose with an mRNA vaccine such as Moderna and Pfizer. According to the published results, there were 129 coronavirus ...

The company is seeking authorisation for a fourth dose of SpikeVax to any adult who has received an initial booster of any of the authorised or approved COVID-19 vaccines. Unlike Pfizer ...

A number of High Street chemists and private clinics sell and administer the Pfizer Covid vaccine directly to the public. The ...

Concerns about the COVID-19 shots have increased after a report that drug maker Moderna failed to inform the U.S. government ...

Six deaths reported this past week in McLeod County were attributed to COVID-19, according to data from the Minnesota Department of Health. It was the deadliest week of the pandemic since last ...

More than 1,000 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, Norway, and North Macedonia. Read more here.

Moderna received the latest telling-off after the U.K. drug marketing watchdog reviewed social media posts and other materials related to the NextCOVE clinical trial of its COVID-19 vaccine.

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS ...

Moderna stock has been under pressure amid declining sales of its COVID-19 vaccine ... in clinical trials that could be the booster shot the stock needs to generate a rebound.

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...